These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 16707444

  • 1. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L, Xiang B, Muthuswamy SK.
    Cancer Res; 2006 May 15; 66(10):5201-8. PubMed ID: 16707444
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C, Lin H, Leonard SS, Shi X, Ye J, Luo J.
    Oncogene; 2003 Aug 14; 22(34):5281-90. PubMed ID: 12917629
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 4. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M, Grijalva R, Yu D.
    Cancer Res; 1999 Apr 01; 59(7):1620-5. PubMed ID: 10197638
    [Abstract] [Full Text] [Related]

  • 5. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
    Tornillo G, Bisaro B, Camacho-Leal Mdel P, Galiè M, Provero P, Di Stefano P, Turco E, Defilippi P, Cabodi S.
    Eur J Cell Biol; 2011 Apr 01; 90(2-3):237-48. PubMed ID: 20961652
    [Abstract] [Full Text] [Related]

  • 6. Sequestration and segregation of receptor kinases in epithelial cells: implications for ErbB2 oncogenesis.
    Carraway CA, Carraway KL.
    Sci STKE; 2007 Apr 10; 2007(381):re3. PubMed ID: 17426346
    [Abstract] [Full Text] [Related]

  • 7. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
    Kassis J, Moellinger J, Lo H, Greenberg NM, Kim HG, Wells A.
    Clin Cancer Res; 1999 Aug 10; 5(8):2251-60. PubMed ID: 10473113
    [Abstract] [Full Text] [Related]

  • 8. The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.
    Chu I, Blackwell K, Chen S, Slingerland J.
    Cancer Res; 2005 Jan 01; 65(1):18-25. PubMed ID: 15665275
    [Abstract] [Full Text] [Related]

  • 9. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
    Mineev KS, Bocharov EV, Pustovalova YE, Bocharova OV, Chupin VV, Arseniev AS.
    J Mol Biol; 2010 Jul 09; 400(2):231-43. PubMed ID: 20471394
    [Abstract] [Full Text] [Related]

  • 10. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R.
    Biochem Biophys Res Commun; 2004 Jun 18; 319(1):1-11. PubMed ID: 15158434
    [Abstract] [Full Text] [Related]

  • 11. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
    Yoon SO, Shin S, Lipscomb EA.
    Cancer Res; 2006 Mar 01; 66(5):2732-9. PubMed ID: 16510594
    [Abstract] [Full Text] [Related]

  • 12. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
    Muthuswamy SK, Gilman M, Brugge JS.
    Mol Cell Biol; 1999 Oct 01; 19(10):6845-57. PubMed ID: 10490623
    [Abstract] [Full Text] [Related]

  • 13. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
    Xia W, Bisi J, Strum J, Liu L, Carrick K, Graham KM, Treece AL, Hardwicke MA, Dush M, Liao Q, Westlund RE, Zhao S, Bacus S, Spector NL.
    Cancer Res; 2006 Feb 01; 66(3):1640-7. PubMed ID: 16452223
    [Abstract] [Full Text] [Related]

  • 14. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B, Ordonez-Ercan D, Fan Z, Huang X, Edgerton SM, Yang X, Thor AD.
    Mol Cancer Res; 2009 Nov 01; 7(11):1882-92. PubMed ID: 19861407
    [Abstract] [Full Text] [Related]

  • 15. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.
    Mol Cancer Res; 2007 Apr 01; 5(4):393-401. PubMed ID: 17426253
    [Abstract] [Full Text] [Related]

  • 16. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
    Sun Y, Lin H, Zhu Y, Ma C, Ye J, Luo J.
    J Cell Physiol; 2002 Aug 01; 192(2):225-33. PubMed ID: 12115729
    [Abstract] [Full Text] [Related]

  • 17. ErbB2-enhanced invasiveness of H-Ras MCF10A breast cells requires MMP-13 and uPA upregulation via p38 MAPK signaling.
    Yong HY, Kim IY, Kim JS, Moon A.
    Int J Oncol; 2010 Feb 01; 36(2):501-7. PubMed ID: 20043086
    [Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer.
    Harari D, Yarden Y.
    Oncogene; 2000 Dec 11; 19(53):6102-14. PubMed ID: 11156523
    [Abstract] [Full Text] [Related]

  • 19. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK, Lee JJ, Yang Y, You KH, Lee JH.
    Carcinogenesis; 2008 Apr 11; 29(4):704-12. PubMed ID: 18258606
    [Abstract] [Full Text] [Related]

  • 20. EGF receptor signalling is essential for electric-field-directed migration of breast cancer cells.
    Pu J, McCaig CD, Cao L, Zhao Z, Segall JE, Zhao M.
    J Cell Sci; 2007 Oct 01; 120(Pt 19):3395-403. PubMed ID: 17881501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.